Teleflex OEM divestiture clears HSR waiting period ahead of anticipated Q3 2026 close

Reuters
03/18
Teleflex OEM divestiture clears HSR waiting period ahead of anticipated Q3 2026 close

Teleflex is pursuing a sale of its Original Equipment and Manufacturing and Development Services business to Lotus US Bidco, an affiliate of Montagu Private Equity and Kohlberg & Co. The transaction is expected to close in Q3 2026. Separately, Teleflex is pursuing a sale of its Acute Care and Interventional Urology business to Intersurgical, and both parties received requests for additional information from the U.S. Federal Trade Commission in connection with the review. That transaction is expected to close in H2 2026, and the two transactions can close independently of each other.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teleflex Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000096943-26-000031), on March 17, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10